Ligand validation:3WR3

GDE: 3,4,5-trihydroxybenzoic acid

GDE is a Ligand Of Interest in 3WR3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WR3_GDE_A_502	50%	53%	0.16	0.911	1	0.84	1	-	1	0	100%	1
3WR9_GDE_B_503	80%	57%	0.106	0.956	1.05	0.62	-	-	0	0	100%	1
3WPM_GDE_B_502	74%	37%	0.125	0.955	1.43	1.05	1	1	2	0	100%	1
3WR4_GDE_B_502	72%	37%	0.129	0.954	1.03	1.41	1	2	2	0	100%	1
3WKU_GDE_A_502	72%	54%	0.147	0.971	0.92	0.86	1	-	2	0	100%	1
3WRB_GDE_A_502	43%	33%	0.169	0.893	0.91	1.74	1	4	0	0	100%	1
7K4O_GDE_A_603	100%	18%	0.038	0.983	1.66	1.88	5	6	2	0	100%	0.9708

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.